Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kelly A Conway

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Current Pharmaceutical Design|February 7, 2003
Emerging beta-amyloid therapies for the treatment of Alzheimer's diseaseKelly A Conway, Ellen W Baxter, Kevin M Felsenstein, et al.
Current Alzheimer Research|July 14, 2007
A comparative analysis of brain and plasma Abeta levels in eight common non-transgenic mouse strains: validation of a specific immunoassay for total rodent AbetaGeorge J Yohrling, Kevin M Felsenstein, Kelly A Conway, et al.
Journal of Molecular Neuroscience : MN|May 6, 2004
Interactions among alpha-synuclein, dopamine, and biomembranes: some clues for understanding neurodegeneration in Parkinson's diseaseJean-Christophe Rochet, Tiago Fleming Outeiro, Kelly A Conway, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 21, 2022
Monoamine oxidase binding not expected to significantly affect [<sup>18</sup>F]flortaucipir PET interpretationJustin P Wright, Jason R Goodman, Yin-Guo Lin, et al.
Bioorganic & Medicinal Chemistry|September 6, 2002
Synthesis of (-)-5,8-dihydroxy-3R-methyl-2R-(dipropylamino)-1,2,3,4-tetrahydronaphthalene: an inhibitor of beta-amyloid(1-42) aggregationMichael H Parker, Robert Chen, Kelly A Conway, et al.
Journal of Biomolecular Screening|July 12, 2003
Virus-based expression systems facilitate rapid target in vivo functionality validation and high-throughput screeningAndrew L Darrow, Kelly A Conway, Anil H Vaidya, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2010
Macrocyclic BACE inhibitors: Optimization of a micromolar hit to nanomolar leadsYifang Huang, Eric D Strobel, Chih Y Ho, et al.
Journal of Medicinal Chemistry|August 10, 2007
2-Amino-3,4-dihydroquinazolines as inhibitors of BACE-1 (beta-site APP cleaving enzyme): Use of structure based design to convert a micromolar hit into a nanomolar leadEllen W Baxter, Kelly A Conway, Ludo Kennis, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Current Pharmaceutical Design|February 7, 2003
Emerging beta-amyloid therapies for the treatment of Alzheimer's diseaseKelly A Conway, Ellen W Baxter, Kevin M Felsenstein, et al.
Current Alzheimer Research|July 14, 2007
A comparative analysis of brain and plasma Abeta levels in eight common non-transgenic mouse strains: validation of a specific immunoassay for total rodent AbetaGeorge J Yohrling, Kevin M Felsenstein, Kelly A Conway, et al.
Journal of Molecular Neuroscience : MN|May 6, 2004
Interactions among alpha-synuclein, dopamine, and biomembranes: some clues for understanding neurodegeneration in Parkinson's diseaseJean-Christophe Rochet, Tiago Fleming Outeiro, Kelly A Conway, et al.
European Journal of Nuclear Medicine and Molecular Imaging|May 21, 2022
Monoamine oxidase binding not expected to significantly affect [<sup>18</sup>F]flortaucipir PET interpretationJustin P Wright, Jason R Goodman, Yin-Guo Lin, et al.
Bioorganic & Medicinal Chemistry|September 6, 2002
Synthesis of (-)-5,8-dihydroxy-3R-methyl-2R-(dipropylamino)-1,2,3,4-tetrahydronaphthalene: an inhibitor of beta-amyloid(1-42) aggregationMichael H Parker, Robert Chen, Kelly A Conway, et al.
Journal of Biomolecular Screening|July 12, 2003
Virus-based expression systems facilitate rapid target in vivo functionality validation and high-throughput screeningAndrew L Darrow, Kelly A Conway, Anil H Vaidya, et al.
Bioorganic & Medicinal Chemistry Letters|April 20, 2010
Macrocyclic BACE inhibitors: Optimization of a micromolar hit to nanomolar leadsYifang Huang, Eric D Strobel, Chih Y Ho, et al.
Journal of Medicinal Chemistry|August 10, 2007
2-Amino-3,4-dihydroquinazolines as inhibitors of BACE-1 (beta-site APP cleaving enzyme): Use of structure based design to convert a micromolar hit into a nanomolar leadEllen W Baxter, Kelly A Conway, Ludo Kennis, et al.
Pageof 1